Form 4: Emerson CEO Granted 350,000 Stock Options
Executive Stock Option Grant
Emerson Electric Co.'s President and CEO, Surendralal Lanca Karsanbhai, was granted 350,000 employee stock options across five tranches on November 13, 2025.
Summary
- Surendralal Lanca Karsanbhai, President & CEO and Director of EMERSON ELECTRIC CO. (EMR), was granted 350,000 employee stock options.
- The grant occurred on November 13, 2025, and was made pursuant to a Rule 10b5-1(c) plan.
- The total grant is divided into five tranches of 70,000 stock options each, with varying exercise prices.
- The exercise prices for the tranches are $128.46, $160.575, $192.69, $224.805, and $256.92.
- Each tranche's exercise price is based on the closing price of the Issuer's common stock on the grant date, with the higher prices representing 125%, 150%, 175%, and 200% of that closing price.
- Each of the five tranches will become exercisable in five equal annual installments of 14,000 options, beginning on November 13, 2026.
- All options have an expiration date of November 13, 2035.
- The grant was made under a shareholder-approved benefit plan and is exempt pursuant to Rule 16b-3(d).
Sentiment
Score: 7
Explanation: The filing reports a routine grant of stock options to a key executive, which is generally positive for aligning management incentives with shareholder interests. It does not contain information about company performance or financial results, so the sentiment is based on corporate governance and executive motivation rather than operational outcomes.
Positives
- The grant of 350,000 stock options to the President & CEO aligns executive incentives with long-term shareholder value creation.
- The options were granted under a shareholder-approved benefit plan, indicating adherence to good corporate governance practices.
- The varying exercise prices, including those significantly above the grant date's closing price, suggest a strong incentive for the CEO to drive substantial stock price appreciation.
Future Outlook
The grant of long-term stock options to the President & CEO indicates a strategic focus on aligning executive performance with the company's long-term growth and shareholder value creation over the next decade, with vesting beginning in 2026 and options expiring in 2035.
Industry Context
The grant of stock options with performance-based exercise prices is a common practice in executive compensation across various industries, particularly in large industrial and technology companies like Emerson Electric. This structure aims to incentivize long-term leadership and align management's financial interests with the sustained growth and profitability of the company, a standard approach to executive retention and motivation.
Comparison to Industry Standards
- The structure of granting stock options in tranches with escalating exercise prices is a common incentive mechanism, similar to practices seen at companies like Honeywell International Inc. (HON) or Siemens AG (SIEGY), which often tie executive compensation to significant stock price appreciation targets.
- The total number of options granted (350,000) to a CEO of a company of Emerson's size is within the typical range for long-term incentive plans, comparable to grants observed at peer industrial automation and software firms.
- The vesting schedule of five equal annual installments beginning a year after the grant date is a standard approach to ensure executive retention and sustained performance over a multi-year period, consistent with best practices in corporate governance for executive equity awards.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Executive Compensation | Grant of 350,000 employee stock options to the President & CEO under a shareholder-approved benefit plan. | 11/13/2025 | Enhances alignment of executive incentives with long-term shareholder value and reinforces the company's compensation strategy for key leadership. |
| Rule 10b5-1 Plan | Transaction made pursuant to a contract, instruction, or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). | 11/13/2025 | Indicates a pre-arranged plan for future transactions, reducing the risk of insider trading allegations and promoting transparency. |
Stakeholder Impact
- Shareholders: The grant of stock options, particularly with escalating exercise prices, incentivizes the CEO to drive significant long-term stock price appreciation, potentially benefiting shareholders.
- Employees: While specific to the CEO, such compensation structures can signal a commitment to long-term performance and a stable leadership, which can positively influence employee morale and retention.
Next Steps
- The stock options will begin to vest in five equal annual installments of 14,000 options per tranche, starting on November 13, 2026.
Key Dates
| Date | Description |
|---|---|
| 11/13/2025 | Date of stock option grant to Surendralal Lanca Karsanbhai. |
| 11/13/2026 | First date each tranche of stock options becomes exercisable in equal annual installments. |
| 11/13/2035 | Expiration date for all granted stock options. |
| 11/14/2025 | Date the Form 4 was signed by the Attorney-in-Fact. |
Keywords
EMR, Emerson Electric, stock options, executive compensation, insider transaction, Form 4, CEO compensation, equity incentive
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.